BioTelemetry Stock Price, News & Analysis (NASDAQ:BEAT)

$33.05 -1.25 (-3.64 %)
(As of 02/22/2018 04:00 PM ET)
Previous Close$33.05
Today's Range$32.55 - $34.40
52-Week Range$23.30 - $39.20
Volume601,928 shs
Average Volume412,423 shs
Market Capitalization$1.11 billion
P/E Ratio25.23
Dividend YieldN/A
Beta0.67

About BioTelemetry (NASDAQ:BEAT)

BioTelemetry logoBioTelemetry, Inc. (BioTelemetry), formerly CardioNet, Inc., provides cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The Company operates in three segments: patient services, product and research services. The patient services business segment's principal focus is on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders, through its core Mobile Cardiac Outpatient Telemetry(MCOT), event and Holter services in a healthcare setting. The product business segment focuses on the development, manufacturing, testing and marketing of medical devices to medical companies, clinics and hospitals. The Company's research services focuses on providing cardiac safety monitoring services for drug and medical treatment trials in a research environment. In August 2012, the Company completed the acquisition of Cardiocore Lab, Inc. (Cardiocore).

Receive BEAT News and Ratings via Email

Sign-up to receive the latest news and ratings for BEAT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Laboratories & Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:BEAT
CUSIPN/A
Phone610-729-7000

Debt

Debt-to-Equity Ratio0.75%
Current Ratio1.60%
Quick Ratio1.48%

Price-To-Earnings

Trailing P/E Ratio25.2290076335878
Forward P/E Ratio39.82
P/E Growth1.47

Sales & Book Value

Annual Sales$208.33 million
Price / Sales5.14
Cash Flow$1.37 per share
Price / Cash24.06
Book Value$4.92 per share
Price / Book6.72

Profitability

Trailing EPS$1.31
Net Income$53.43 million
Net Margins16.10%
Return on Equity13.66%
Return on Assets8.44%

Miscellaneous

Employees1,087
Outstanding Shares32,410,000

BioTelemetry (NASDAQ:BEAT) Frequently Asked Questions

What is BioTelemetry's stock symbol?

BioTelemetry trades on the NASDAQ under the ticker symbol "BEAT."

How were BioTelemetry's earnings last quarter?

BioTelemetry, Inc. (NASDAQ:BEAT) announced its quarterly earnings data on Tuesday, February, 20th. The medical research company reported $0.32 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.09. The medical research company had revenue of $91.70 million for the quarter, compared to the consensus estimate of $88.33 million. BioTelemetry had a return on equity of 13.66% and a net margin of 16.10%. The firm's revenue was up 69.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.23 EPS. View BioTelemetry's Earnings History.

When will BioTelemetry make its next earnings announcement?

BioTelemetry is scheduled to release their next quarterly earnings announcement on Thursday, February, 22nd 2018. View Earnings Estimates for BioTelemetry.

Where is BioTelemetry's stock going? Where will BioTelemetry's stock price be in 2018?

7 brokers have issued 1 year price targets for BioTelemetry's stock. Their forecasts range from $37.00 to $50.00. On average, they expect BioTelemetry's stock price to reach $43.50 in the next twelve months. View Analyst Ratings for BioTelemetry.

Who are some of BioTelemetry's key competitors?

Who owns BioTelemetry stock?

BioTelemetry's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (12.63%), Bank of New York Mellon Corp (3.97%), Hood River Capital Management LLC (3.67%), Glenmede Trust Co. NA (3.32%), Macquarie Group Ltd. (2.33%) and Renaissance Technologies LLC (1.73%). Company insiders that own BioTelemetry stock include Daniel Wisniewski, Fred Broadway, George Hrenko, Heather C Getz, Joseph H Capper, Peter Ferola and Robert J Rubin. View Institutional Ownership Trends for BioTelemetry.

Who sold BioTelemetry stock? Who is selling BioTelemetry stock?

BioTelemetry's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Bank of New York Mellon Corp, Globeflex Capital L P, Hodges Capital Management Inc., Wells Fargo & Company MN, Goldman Sachs Group Inc., KBC Group NV and Falcon Point Capital LLC. Company insiders that have sold BioTelemetry company stock in the last year include Fred Broadway, George Hrenko and Robert J Rubin. View Insider Buying and Selling for BioTelemetry.

Who bought BioTelemetry stock? Who is buying BioTelemetry stock?

BioTelemetry's stock was bought by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Sterling Capital Management LLC, Rice Hall James & Associates LLC, Lyon Street Capital LLC, Hood River Capital Management LLC, BlackRock Inc., Thomson Horstmann & Bryant Inc. and Allianz Asset Management GmbH. View Insider Buying and Selling for BioTelemetry.

How do I buy BioTelemetry stock?

Shares of BioTelemetry can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BioTelemetry's stock price today?

One share of BioTelemetry stock can currently be purchased for approximately $33.05.

How big of a company is BioTelemetry?

BioTelemetry has a market capitalization of $1.11 billion and generates $208.33 million in revenue each year. The medical research company earns $53.43 million in net income (profit) each year or $1.31 on an earnings per share basis. BioTelemetry employs 1,087 workers across the globe.

How can I contact BioTelemetry?

BioTelemetry's mailing address is 1000 Cedar Hollow Road, Malvern PA, 19355. The medical research company can be reached via phone at 610-729-7000 or via email at [email protected]


MarketBeat Community Rating for BioTelemetry (BEAT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  185 (Vote Outperform)
Underperform Votes:  170 (Vote Underperform)
Total Votes:  355
MarketBeat's community ratings are surveys of what our community members think about BioTelemetry and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

BioTelemetry (NASDAQ:BEAT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.712.712.753.00
Ratings Breakdown: 1 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $43.50$43.50$43.50$45.75
Price Target Upside: 70.09% upside70.09% upside70.09% upside38.43% upside

BioTelemetry (NASDAQ:BEAT) Consensus Price Target History

Price Target History for BioTelemetry (NASDAQ:BEAT)

BioTelemetry (NASDAQ:BEAT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/8/2017Dougherty & CoReiterated RatingBuy$40.00N/AView Rating Details
10/26/2017Raymond James FinancialInitiated CoverageOutperform$37.00N/AView Rating Details
10/23/2017SunTrust BanksInitiated CoverageBuy$41.00N/AView Rating Details
9/15/2017Off Wall StreetInitiated CoverageSellMediumView Rating Details
8/10/2017SidotiReiterated RatingBuy$42.00 -> $49.00LowView Rating Details
7/19/2017BenchmarkBoost Price TargetBuy -> Buy$38.00 -> $44.00LowView Rating Details
7/14/2017Lake Street CapitalReiterated RatingBuy$35.00 -> $50.00HighView Rating Details
12/13/2016GabelliReiterated RatingBuyN/AView Rating Details
(Data available from 2/22/2016 forward)

Earnings

BioTelemetry (NASDAQ:BEAT) Earnings History and Estimates Chart

Earnings by Quarter for BioTelemetry (NASDAQ:BEAT)

BioTelemetry (NASDAQ BEAT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/22/2018        
2/20/2018Q4 2017$0.23$0.32$88.33 million$91.70 millionViewN/AView Earnings Details
11/7/2017Q3 2017$0.25$0.16$82.10 million$81.02 millionViewN/AView Earnings Details
8/8/2017Q2 2017$0.21$0.23$58.39 million$58.10 millionViewListenView Earnings Details
5/3/2017Q1 2017$0.14$0.16$55.11 million$55.88 millionViewListenView Earnings Details
2/22/2017Q4 2016$0.18$0.23$53.75 million$53.96 millionViewListenView Earnings Details
11/2/2016Q316$0.18$0.21$52.92 million$53.10 millionViewN/AView Earnings Details
8/2/2016Q2$0.17$0.20$50.27 million$52.68 millionViewListenView Earnings Details
4/26/2016Q1$0.10$0.20$46.54 million$48.60 millionViewListenView Earnings Details
2/17/2016Q415$0.11$0.15$45.89 million$46.70 millionViewListenView Earnings Details
11/9/2015Q3$0.11$0.13$46.05 million$43.49 millionViewN/AView Earnings Details
8/6/2015Q2$0.09$0.12$45.75 million$44.81 millionViewListenView Earnings Details
5/6/2015Q115$0.02$0.06$43.80 million$43.40 millionViewListenView Earnings Details
2/19/2015Q414$0.06$0.05$43.40 million$43.70 millionViewListenView Earnings Details
10/30/2014Q214$0.01$0.06$42.00 million$43.00 millionViewListenView Earnings Details
7/31/2014Q114$0.01$0.02$40.95 million$42.70 millionViewListenView Earnings Details
5/6/2014Q413($0.02)($0.04)$38.40 million$37.16 millionViewListenView Earnings Details
2/26/2014Q313($0.04)$0.05$32.26 million$33.10 millionViewListenView Earnings Details
11/5/2013($0.05)($0.12)$32.79 million$31.90 millionViewListenView Earnings Details
7/30/2013Q2 2013$0.02$27.50 million$32.10 millionViewListenView Earnings Details
4/22/2013Q1 2013($0.03)$32.42 millionViewN/AView Earnings Details
2/13/2013Q4 2012($0.09)$26.80 million$30.00 millionViewListenView Earnings Details
11/5/2012Q312($0.09)($0.08)$26.49 million$27.00 millionViewN/AView Earnings Details
8/8/2012($0.04)($0.01)ViewN/AView Earnings Details
5/8/2012($0.12)($0.10)ViewN/AView Earnings Details
2/22/2012($0.13)($0.04)ViewN/AView Earnings Details
11/8/2011($0.09)($0.21)ViewN/AView Earnings Details
8/8/2011($0.06)($0.05)ViewN/AView Earnings Details
5/3/2011($0.15)($0.02)ViewN/AView Earnings Details
2/17/2011($0.16)($0.13)ViewN/AView Earnings Details
11/8/2010Q3 2010($0.05)($0.25)ViewN/AView Earnings Details
7/28/2010Q2 2010($0.10)($0.09)ViewN/AView Earnings Details
4/28/2010Q1 2010($0.18)($0.13)ViewN/AView Earnings Details
2/17/2010Q4 2009($0.12)($0.24)ViewN/AView Earnings Details
11/6/2009Q3 2009$0.03($0.11)ViewN/AView Earnings Details
8/5/2009Q2 2009$0.05$0.06ViewN/AView Earnings Details
4/30/2009Q1 2009$0.05$0.04ViewN/AView Earnings Details
2/17/2009Q4 2008$0.15$0.16ViewN/AView Earnings Details
10/30/2008Q3 2008$0.10$0.11ViewN/AView Earnings Details
7/22/2008Q2 2008$0.07$0.08ViewN/AView Earnings Details
4/29/2008Q1 2008$0.02ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

BioTelemetry (NASDAQ:BEAT) Earnings Estimates

2018 EPS Consensus Estimate: $1.06
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.22$0.22$0.22
Q2 20181$0.27$0.27$0.27
Q3 20181$0.28$0.28$0.28
Q4 20181$0.29$0.29$0.29
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for BioTelemetry (NASDAQ:BEAT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

BioTelemetry (NASDAQ BEAT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 9.60%
Institutional Ownership Percentage: 83.93%
Insider Trades by Quarter for BioTelemetry (NASDAQ:BEAT)
Institutional Ownership by Quarter for BioTelemetry (NASDAQ:BEAT)

BioTelemetry (NASDAQ BEAT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/15/2017Robert J. RubinDirectorSell15,000$28.14$422,100.00View SEC Filing  
3/20/2017Fred BroadwaySVPSell3,429$26.90$92,240.1025,420View SEC Filing  
2/27/2017George HrenkoSVPSell126,043$25.95$3,270,815.8523,172View SEC Filing  
2/21/2017Fred BroadwaySVPSell8,070$24.81$200,216.7028,849View SEC Filing  
9/19/2016George HrenkoSVPSell1,061$18.50$19,628.5037,568View SEC Filing  
9/13/2016Heather C GetzCFOSell5,866$18.23$106,937.1844,293View SEC Filing  
9/13/2016Joseph H CapperInsiderSell26,847$18.23$489,420.81189,838View SEC Filing  
9/13/2016Peter FerolaGeneral CounselSell4,352$18.23$79,336.9630,989View SEC Filing  
9/9/2016Fred BroadwaySVPSell3,146$17.84$56,124.6437,886View SEC Filing  
9/8/2016George HrenkoSVPSell3,491$18.06$63,047.4642,500View SEC Filing  
9/8/2016Heather C GetzCFOSell2,979$18.10$53,919.9050,159View SEC Filing  
9/8/2016Joseph H CapperInsiderSell13,632$18.10$246,739.20216,685View SEC Filing  
9/8/2016Peter FerolaGeneral CounselSell2,210$18.10$40,001.0028,847View SEC Filing  
9/7/2016Daniel WisniewskiSVPSell9,225$18.51$170,754.7538,672View SEC Filing  
9/7/2016Heather C GetzCFOSell18,945$18.52$350,861.4065,536View SEC Filing  
9/7/2016Joseph H CapperInsiderSell86,681$18.52$1,605,332.12287,045View SEC Filing  
9/7/2016Peter FerolaGeneral CounselSell14,053$18.52$260,261.5626,637View SEC Filing  
9/6/2016Fred BroadwaySVPSell4,662$18.28$85,221.3652,379View SEC Filing  
9/6/2016Heather C GetzCFOSell6,686$18.29$122,286.9465,536View SEC Filing  
9/6/2016Joseph H CapperCEOSell30,595$18.29$559,582.55287,045View SEC Filing  
9/6/2016Peter FerolaGeneral CounselSell4,960$18.29$90,718.4026,637View SEC Filing  
9/2/2016Fred BroadwaySVPSell4,466$18.75$83,737.5052,379View SEC Filing  
9/2/2016Heather C GetzCFOSell6,547$18.75$122,756.2565,536View SEC Filing  
9/2/2016Joseph H CapperCEOSell29,953$18.75$561,618.75287,045View SEC Filing  
9/2/2016Peter FerolaGeneral CounselSell4,856$18.75$91,050.0026,637View SEC Filing  
9/1/2016Fred BroadwaySVPSell7,525$19.25$144,856.2561,756View SEC Filing  
9/1/2016Heather C GetzCFOSell10,408$18.59$193,484.7278,721View SEC Filing  
9/1/2016Joseph H CapperInsiderSell47,622$18.59$885,292.98347,373View SEC Filing  
9/1/2016Peter FerolaGeneral CounselSell7,722$18.59$143,551.9835,177View SEC Filing  
8/30/2016Fred BroadwaySVPSell12,121$19.07$231,147.4771,719View SEC Filing  
8/30/2016Heather C GetzCFOSell17,482$19.07$333,381.7493,091View SEC Filing  
8/30/2016Joseph H CapperInsiderSell79,986$19.07$1,525,333.02413,117View SEC Filing  
8/30/2016Peter FerolaGeneral CounselSell12,970$19.07$247,337.9045,838View SEC Filing  
8/25/2016Fred BroadwaySVPSell5,877$19.16$112,603.3276,491View SEC Filing  
8/25/2016Heather C GetzCFOSell8,477$19.16$162,419.3299,973View SEC Filing  
8/25/2016Joseph H CapperInsiderSell38,785$19.16$743,120.60450,606View SEC Filing  
8/25/2016Peter FerolaGeneral CounselSell6,289$19.16$120,497.2450,944View SEC Filing  
8/24/2016George HrenkoSVPSell7,473$20.11$150,282.03103,888View SEC Filing  
8/24/2016Heather C GetzCFOSell8,778$20.11$176,525.58120,945View SEC Filing  
8/24/2016Joseph H CapperCEOSell40,160$20.11$807,617.60546,559View SEC Filing  
8/24/2016Peter FerolaGeneral CounselSell6,512$20.11$130,956.3266,503View SEC Filing  
8/23/2016George HrenkoSVPSell3,165$20.67$65,420.55103,888View SEC Filing  
8/23/2016Heather C GetzCFOSell3,717$20.67$76,830.39120,945View SEC Filing  
8/23/2016Joseph H CapperCEOSell17,008$20.67$351,555.36546,559View SEC Filing  
8/23/2016Peter FerolaGeneral CounselSell2,758$20.67$57,007.8666,503View SEC Filing  
8/22/2016George HrenkoSVPSell4,149$20.85$86,506.65103,888View SEC Filing  
8/22/2016Heather C GetzCFOSell4,874$20.85$101,622.90120,945View SEC Filing  
8/22/2016Joseph H CapperCEOSell22,298$20.85$464,913.30546,559View SEC Filing  
8/22/2016Peter FerolaGeneral CounselSell3,616$20.85$75,393.6066,503View SEC Filing  
8/19/2016Daniel WisniewskiSVPSell9,025$20.96$189,164.0068,501View SEC Filing  
8/19/2016Heather C GetzCFOSell9,026$20.96$189,184.96125,819View SEC Filing  
8/19/2016Joseph H CapperInsiderSell9,049$20.96$189,667.04568,857View SEC Filing  
8/19/2016Peter FerolaGeneral CounselSell9,035$20.96$189,373.6070,119View SEC Filing  
5/9/2014Ronald AhrensDirectorBuy6,000$7.37$44,220.00187,629View SEC Filing  
11/12/2013Ronald AhrensDirectorBuy5,000$11.73$58,650.00164,467View SEC Filing  
11/12/2012Ronald A AhrensDirectorBuy15,000$2.22$33,300.00View SEC Filing  
9/5/2012Joseph H CapperCEOBuy23,540$2.25$52,965.00View SEC Filing  
8/31/2012Joseph H CapperCEOBuy2,600$2.28$5,928.00View SEC Filing  
8/29/2012Joseph H CapperCEOBuy10,800$2.30$24,840.00View SEC Filing  
8/28/2012Joseph H CapperCEOBuy1,300$2.19$2,847.00View SEC Filing  
8/27/2012Joseph H CapperCEOBuy1,600$2.12$3,392.00View SEC Filing  
8/23/2012Joseph H CapperCEOBuy9,600$2.08$19,968.00View SEC Filing  
8/20/2012Joseph H CapperCEOBuy14,160$1.97$27,895.20View SEC Filing  
8/17/2012Joseph H CapperCEOBuy9,800$2.10$20,580.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

BioTelemetry (NASDAQ BEAT) News Headlines

Source:
DateHeadline
BioTelemetry (BEAT) Announces Quarterly  Earnings ResultsBioTelemetry (BEAT) Announces Quarterly Earnings Results
www.americanbankingnews.com - February 22 at 9:32 PM
BioTelemetry, Inc. Reports Fourth Quarter 2017 Financial ResultsBioTelemetry, Inc. Reports Fourth Quarter 2017 Financial Results
finance.yahoo.com - February 22 at 5:44 PM
BioTelemetry Q4 Earnings PreviewBioTelemetry Q4 Earnings Preview
finance.yahoo.com - February 22 at 5:44 PM
BidaskClub Upgrades BioTelemetry (BEAT) to "Buy"BidaskClub Upgrades BioTelemetry (BEAT) to "Buy"
www.americanbankingnews.com - February 18 at 3:32 PM
BioTelemetry, Inc. (BEAT) Given Consensus Recommendation of "Hold" by AnalystsBioTelemetry, Inc. (BEAT) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - February 13 at 1:44 PM
BioTelemetry, Inc. to Release Fourth Quarter 2017 Earnings Results on February 22, 2018BioTelemetry, Inc. to Release Fourth Quarter 2017 Earnings Results on February 22, 2018
finance.yahoo.com - February 13 at 8:37 AM
BioTelemetry (BEAT) Set to Announce Quarterly Earnings on TuesdayBioTelemetry (BEAT) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - February 13 at 2:38 AM
Zacks Investment Research Lowers BioTelemetry (BEAT) to SellZacks Investment Research Lowers BioTelemetry (BEAT) to Sell
www.americanbankingnews.com - February 8 at 6:00 PM
BioTelemetry (BEAT) Stock Rating Lowered by BidaskClubBioTelemetry (BEAT) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - February 3 at 8:46 PM
BEAT Makes Notable Cross Below Critical Moving AverageBEAT Makes Notable Cross Below Critical Moving Average
www.nasdaq.com - February 3 at 8:22 AM
BioTelemetry (BEAT) Rating Lowered to Sell at Zacks Investment ResearchBioTelemetry (BEAT) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - January 31 at 6:40 PM
$88.33 Million in Sales Expected for BioTelemetry, Inc. (BEAT) This Quarter$88.33 Million in Sales Expected for BioTelemetry, Inc. (BEAT) This Quarter
www.americanbankingnews.com - January 26 at 2:00 AM
Zacks Investment Research Upgrades BioTelemetry (BEAT) to "Hold"Zacks Investment Research Upgrades BioTelemetry (BEAT) to "Hold"
www.americanbankingnews.com - January 22 at 6:36 PM
BioTelemetry, Inc. (BEAT) Given Consensus Rating of "Hold" by AnalystsBioTelemetry, Inc. (BEAT) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - January 19 at 3:40 PM
BioTelemetry, Inc. (BEAT) Short Interest UpdateBioTelemetry, Inc. (BEAT) Short Interest Update
www.americanbankingnews.com - January 12 at 2:38 AM
BEAT Makes Bullish Cross Above Critical Moving AverageBEAT Makes Bullish Cross Above Critical Moving Average
www.nasdaq.com - January 11 at 3:31 PM
BioTelemetry, Inc. (BEAT) Expected to Announce Quarterly Sales of $88.33 MillionBioTelemetry, Inc. (BEAT) Expected to Announce Quarterly Sales of $88.33 Million
www.americanbankingnews.com - January 9 at 4:06 AM
BioTelemetry, Inc. (BEAT) Expected to Announce Earnings of $0.21 Per ShareBioTelemetry, Inc. (BEAT) Expected to Announce Earnings of $0.21 Per Share
www.americanbankingnews.com - January 7 at 7:26 PM
ETFs with exposure to BioTelemetry, Inc. : December 29, 2017ETFs with exposure to BioTelemetry, Inc. : December 29, 2017
finance.yahoo.com - December 29 at 3:30 PM
BioTelemetry, Inc. :BEAT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 28, 2017BioTelemetry, Inc. :BEAT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 28, 2017
finance.yahoo.com - December 28 at 9:53 AM
BioTelemetry (BEAT) Upgraded at BidaskClubBioTelemetry (BEAT) Upgraded at BidaskClub
www.americanbankingnews.com - December 27 at 9:04 PM
BioTelemetry, Inc. (BEAT) Receives Average Recommendation of "Hold" from AnalystsBioTelemetry, Inc. (BEAT) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - December 25 at 1:52 PM
BioTelemetry (BEAT) Lifted to Sell at BidaskClubBioTelemetry (BEAT) Lifted to Sell at BidaskClub
www.americanbankingnews.com - December 24 at 12:28 PM
Zacks: Analysts Anticipate BioTelemetry, Inc. (BEAT) Will Post Quarterly Sales of $88.33 MillionZacks: Analysts Anticipate BioTelemetry, Inc. (BEAT) Will Post Quarterly Sales of $88.33 Million
www.americanbankingnews.com - December 24 at 7:04 AM
 Analysts Anticipate BioTelemetry, Inc. (BEAT) Will Post Earnings of $0.21 Per Share Analysts Anticipate BioTelemetry, Inc. (BEAT) Will Post Earnings of $0.21 Per Share
www.americanbankingnews.com - December 22 at 11:26 AM
Stocks Showing Improved Relative Strength: BioTelemetryStocks Showing Improved Relative Strength: BioTelemetry
finance.yahoo.com - December 20 at 3:28 PM
This Mornings Technical Outlook on Medical Research Stocks -- Organovo, BioTelemetry, Bruker, and PerkinElmer - PR Newswire (press release)This Morning's Technical Outlook on Medical Research Stocks -- Organovo, BioTelemetry, Bruker, and PerkinElmer - PR Newswire (press release)
www.prnewswire.com - December 18 at 9:47 AM
BioTelemetry, Inc. – Value Analysis (NASDAQ:BEAT) : December 15, 2017BioTelemetry, Inc. – Value Analysis (NASDAQ:BEAT) : December 15, 2017
finance.yahoo.com - December 15 at 3:33 PM
Short Interest in BioTelemetry, Inc. (BEAT) Increases By 32.8%Short Interest in BioTelemetry, Inc. (BEAT) Increases By 32.8%
www.americanbankingnews.com - December 15 at 3:08 AM
BioTelemetry, Inc. breached its 50 day moving average in a Bearish Manner : BEAT-US : December 14, 2017BioTelemetry, Inc. breached its 50 day moving average in a Bearish Manner : BEAT-US : December 14, 2017
finance.yahoo.com - December 14 at 9:51 AM
Critical Comparison: BG Medicine (BGMD) vs. BioTelemetry (BEAT)Critical Comparison: BG Medicine (BGMD) vs. BioTelemetry (BEAT)
www.americanbankingnews.com - December 12 at 9:34 PM
Reviewing BG Medicine (BGMD) and BioTelemetry (BEAT)Reviewing BG Medicine (BGMD) and BioTelemetry (BEAT)
www.americanbankingnews.com - December 11 at 11:26 AM
Analyzing BG Medicine (BGMD) & BioTelemetry (BEAT)Analyzing BG Medicine (BGMD) & BioTelemetry (BEAT)
www.americanbankingnews.com - December 9 at 8:04 AM
Head to Head Analysis: BioTelemetry (BEAT) & Cannabis Science (CBIS)Head to Head Analysis: BioTelemetry (BEAT) & Cannabis Science (CBIS)
www.americanbankingnews.com - December 9 at 3:14 AM
Head-To-Head Analysis: BG Medicine (BGMD) vs. BioTelemetry (BEAT)Head-To-Head Analysis: BG Medicine (BGMD) vs. BioTelemetry (BEAT)
www.americanbankingnews.com - December 7 at 5:30 PM
BioTelemetry: Key Partnership In Apples Heart Study Featuring Apples Watch - Seeking AlphaBioTelemetry: Key Partnership In Apple's Heart Study Featuring Apple's Watch - Seeking Alpha
seekingalpha.com - December 7 at 9:54 AM
Reviewing BioTelemetry (BEAT) & BG Medicine (BGMD)Reviewing BioTelemetry (BEAT) & BG Medicine (BGMD)
www.americanbankingnews.com - December 5 at 7:52 PM
BioTelemetrys (BEAT) Telcare Unit Collaborates With Onduo - NasdaqBioTelemetry's (BEAT) Telcare Unit Collaborates With Onduo - Nasdaq
www.nasdaq.com - December 3 at 3:29 PM
Critical Review: BG Medicine (BGMD) & BioTelemetry (BEAT)Critical Review: BG Medicine (BGMD) & BioTelemetry (BEAT)
www.americanbankingnews.com - December 1 at 7:30 PM
BioTelemetrys (BEAT) Telcare Unit Collaborates With OnduoBioTelemetry's (BEAT) Telcare Unit Collaborates With Onduo
finance.yahoo.com - December 1 at 1:03 PM
BioTelemetry Ties Up With Apple, Grows in Cardiac MonitoringBioTelemetry Ties Up With Apple, Grows in Cardiac Monitoring
finance.yahoo.com - December 1 at 1:03 PM
BioTelemetry's (BEAT) Telcare Unit Collaborates With OnduoBioTelemetry's (BEAT) Telcare Unit Collaborates With Onduo
finance.yahoo.com - December 1 at 1:03 PM
BioTelemetry, Inc. (BEAT) Given Consensus Rating of "Buy" by BrokeragesBioTelemetry, Inc. (BEAT) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - November 30 at 4:04 PM
Apple Doesn't Need Next Big Thing For A While, Analyst SaysApple Doesn't Need Next Big Thing For A While, Analyst Says
finance.yahoo.com - November 30 at 3:29 PM
BioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart StudyBioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study
finance.yahoo.com - November 30 at 10:01 AM
Critical Survey: BG Medicine (BGMD) versus BioTelemetry (BEAT)Critical Survey: BG Medicine (BGMD) versus BioTelemetry (BEAT)
www.americanbankingnews.com - November 29 at 9:08 AM
BIIB & ALKS Team Up For MS Drug, REGNs Eylea Combo Fails Again, AEZS RisesBIIB & ALKS Team Up For MS Drug, REGN's Eylea Combo Fails Again, AEZS Rises
www.rttnews.com - November 28 at 9:04 AM
Analyzing BG Medicine (BGMD) and BioTelemetry (BEAT)Analyzing BG Medicine (BGMD) and BioTelemetry (BEAT)
www.americanbankingnews.com - November 28 at 7:44 AM
Head-To-Head Survey: BG Medicine (BGMD) & BioTelemetry (BEAT)Head-To-Head Survey: BG Medicine (BGMD) & BioTelemetry (BEAT)
www.americanbankingnews.com - November 27 at 5:56 AM
Financial Survey: BG Medicine (BGMD) and BioTelemetry (BEAT)Financial Survey: BG Medicine (BGMD) and BioTelemetry (BEAT)
www.americanbankingnews.com - November 26 at 9:24 AM

SEC Filings

BioTelemetry (NASDAQ:BEAT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

BioTelemetry (NASDAQ:BEAT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

BioTelemetry (NASDAQ BEAT) Stock Chart for Thursday, February, 22, 2018

Loading chart…

This page was last updated on 2/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.